Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Long-Term Investments (2018 - 2022)

Historic Long-Term Investments for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Q1 2022 value amounting to $131000.0.

  • Arcturus Therapeutics Holdings' Long-Term Investments fell 8950.32% to $131000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $131000.0, marking a year-over-year decrease of 8950.32%. This contributed to the annual value of $515000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q1 2022, Arcturus Therapeutics Holdings' Long-Term Investments is $131000.0, which was down 8950.32% from $515000.0 recorded in Q4 2021.
  • In the past 5 years, Arcturus Therapeutics Holdings' Long-Term Investments registered a high of $1.2 million during Q1 2021, and its lowest value of $100000.0 during Q1 2020.
  • For the 5-year period, Arcturus Therapeutics Holdings' Long-Term Investments averaged around $493111.1, with its median value being $303000.0 (2019).
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Long-Term Investments soared by 114800.0% in 2021 and then plummeted by 8950.32% in 2022.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Long-Term Investments stood at $288000.0 in 2018, then decreased by 8.68% to $263000.0 in 2019, then tumbled by 61.98% to $100000.0 in 2020, then soared by 415.0% to $515000.0 in 2021, then crashed by 74.56% to $131000.0 in 2022.
  • Its Long-Term Investments was $131000.0 in Q1 2022, compared to $515000.0 in Q4 2021 and $670000.0 in Q3 2021.